The ministry of health in Israel has said that it has found that cases of Myocarditis observed mainly in young men who received Pfizer’s COVID-19 vaccine in Israel, were likely linked to their vaccination.
Pfizer pharmaceuticals has said it is yet to observed a higher rate of the condition, but Israel has reported 275 cases of the heart disease and still counting between December 2020 and May 2021.
The team commissioned to examine the matter reported that “there is a probable link between receiving the second dose (of Pfizer) vaccine and the appearance of myocarditis among men aged 16 to 30.”
Most patients who experienced heart inflammation spent no more than four days in the hospital and the cases where more prominent between males from ages 16-19.
Israel had held off making its 12- to 15-year-old population eligible for the vaccines, pending the Health Ministry report.
A U.S. Centers for Disease Control and Prevention advisory group last month recommended further study of the possibility of a link between myocarditis and mRNA vaccines, which include those from Pfizer and Moderna Inc.
Discover more from LN247
Subscribe to get the latest posts sent to your email.
